Shares of Tesaro soared early Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker.
When our award-winning analyst team hasa stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,Motley Fool Stock Advisor, has tripled the market.* They just revealed what they believe are theten best stocksfor investors to buy right now... and Gla...
GlaxoSmithKline Plans [Pounds Sterling]4bn Buyback of SharesRead the full-text online article and more details about "GlaxoSmithKline Plans [Pounds Sterling]4bn Buyback of Shares" by Walsh, Fiona - The Evening Standard (London, England), October 23, 2001By WalshFiona...
In a report issued on January 14, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Opthea Limited, with a price target of A$1.25. The company’s shares closed last Thursday at $0.44, equals to its 52-week low of $0.44. Accordin...
The latest proposal from Unilever valued the consumer healthcare unit at £50 billion, made up of £41.7 billion in cash and £8.3 billion in Unilever shares. GlaxoSmithKline says it rejected all the acquisition proposals because they fundamentally undervalue the unit and its prospects. Th...
In the U.S., the FDA approval in asthma in September had a hugely galvanizing effect with two thirds of HCP's recognizing the uniqueness of our dual indication and we've just seen the prescribing by allergists saw. As a consequence, Telegy's market shares continue to build and in fact ...